Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.3360
-0.0140 (-4.00%)
At close: Apr 23, 2025, 4:00 PM
0.3300
-0.0060 (-1.79%)
After-hours: Apr 23, 2025, 5:14 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $20.88 million as of April 23, 2025. Its market cap has decreased by -73.74% in one year.
Market Cap
20.88M
Enterprise Value
-30.40M
1-Year Change
-73.74%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $20.88M, a decrease of -97.82%. That is a compound annual growth rate of -52.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 21.75M | -37.90% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 389.05B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |